Fig. 2
From: Right- and left-sided colorectal cancers respond differently to cetuximab

Kaplan–Meier survival estimates of metastatic colorectal cancer patients with second-line therapy. a, PFS curves of RSCC patients. b, OS curves of RSCC patients. c, PFS curves of LSCRC patients. d, OS curves of LSCRC patients